Exploring how telehealth can help patients with end stage kidney disease in rural areas
Evaluating the role of telehealth in patients with end stage kidney disease (ESKD)
This study is looking at how using telehealth can help people with end stage kidney disease who live in rural areas get better access to care, and it will also find out what patients and doctors think about using telehealth instead of going to the office.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-10909037 on NIH RePORTER |
What this research studies
This research investigates the use of telehealth to improve access to care for patients with end stage kidney disease (ESKD) living in rural areas. It aims to assess the costs, utilization, and outcomes of telehealth services compared to traditional in-office visits. The study will also explore the preferences of both patients and healthcare providers regarding telehealth, identifying barriers and facilitators to its use. By understanding these factors, the research seeks to enhance telehealth policies tailored for rural ESKD patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are rural patients diagnosed with end stage kidney disease who may struggle to access traditional healthcare services.
Not a fit: Patients living in urban areas or those who do not have end stage kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to nephrology care and enhance the quality of life for rural patients with end stage kidney disease.
How similar studies have performed: Previous research has shown promising results in using telehealth to improve healthcare access, particularly in rural populations, indicating potential success for this approach.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Adler, Joel Thomas — University of Texas at Austin
- Study coordinator: Adler, Joel Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.